scorecard
  1. Home
  2. Science
  3. Health
  4. news
  5. The FDA is set to review Pfizer's coronavirus vaccine for kids 5- to 11-years old

The FDA is set to review Pfizer's coronavirus vaccine for kids 5- to 11-years old

Leah Rosenbaum   

The FDA is set to review Pfizer's coronavirus vaccine for kids 5- to 11-years old

Hello,

Welcome to Insider Healthcare. I'm healthcare editor Leah Rosenbaum, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lrosenbaum@insider.com or tweet @leah_rosenbaum. Let's get to it...


The Pfizer-BioNTech COVID-19 vaccine is 91% effective in 5- to 11-year-olds, new study results find

See the full story>>


The head of JPMorgan's new health bet reveals the 3 decisions that persuaded him to come aboard even after the bank's previous venture flopped

Check it out>>


Salmonella linked to onions has infected more than 650 people in 37 states, CDC says

Read more now>>


More stories we're reading:


-Leah

READ MORE ARTICLES ON




Advertisement